Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABO-incompatible renal transplantation

H Toma1

  • 1Department of Urology, Tokyo Women's Medical College, Japan.

The Urologic Clinics of North America
|May 1, 1994
PubMed
Summary

ABO-incompatible renal transplantation is a viable option when no other donor is available, offering comparable patient and graft survival rates. While acute humoral rejection can occur, it is often manageable with effective antirejection therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Living Related Renal Transplantation Using a Saphenous Vein Graft: A Case Report.

Transplantation proceedings·2018
Same author

Clinical outcomes of recipients with aplastic bone disease after renal transplantation.

Transplantation proceedings·2012
Same author

Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.

Cancer gene therapy·2010
Same author

Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.

The Journal of pathology·2007
Same author

Thickening of the peritubular capillary basement membrane is a useful diagnostic marker of chronic rejection in renal allografts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • Renal transplantation across ABO incompatibility is increasingly accepted when alternative donors are unavailable.
  • Outcomes approach those of ABO-compatible transplants, despite immunological challenges.

Purpose of the Study:

  • To evaluate the efficacy and challenges of ABO-incompatible renal transplantation.
  • To highlight the importance of immunologic preparation and monitoring.

Main Methods:

  • Review of recent works on ABO-incompatible renal transplantation.
  • Analysis of rejection mechanisms and therapeutic strategies.
  • Assessment of patient and graft survival rates.

Main Results:

  • Patient and graft survival rates are comparable to ABO-compatible renal transplantation.
  • Acute humoral rejection is the most common early complication but is often treatable.
  • Hyperacute rejection can still occur despite antibody removal.

Conclusions:

  • ABO-incompatible renal transplantation is a feasible option with acceptable outcomes.
  • Immunologic preparation, including antibody titer reduction and splenectomy, is crucial.
  • Ongoing research into rejection mechanisms is needed for further optimization.

Related Experiment Videos